About
Personalized cancer therapy
Areas of Focus
Categories
Small Molecule PharmaceuticalAI FocusedSouthwestern U.S.
Team (31)
Alheidis Merschel
Senior Consultant GxP Services / Qualified Person
Lantern Pharma
team_member
Anja Heinrich, M.Sc.
Senior Consultant / Head Medical Devices
Lantern Pharma
team_member
Birgit Schulz
Senior Consultant GxP Services / Qualified Person
Lantern Pharma
team_member
Dipl.-Ing. (FH) Elisabeth Teuber
Senior Consultant Medical Devices
Lantern Pharma
team_member
Dr. Astrid Dittmer-Oelmann
Senior Consultant Regulatory Affairs Pharma
Lantern Pharma
team_member
Dr. Christine Roser
Senior Consultant Regulatory Affairs Pharma
Lantern Pharma
team_member
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
390
By Phase
PHASE1/PHASE2: 1PHASE2: 2PHASE1: 1
By Status
RECRUITING: 3COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT05933265Lead Sponsor
Study of LP-184 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
175 participants
Started: Jun 9, 2023 · Completed: Sep 9, 2025
NCT05456256Lead Sponsor
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
PHASE2Recruiting
90 participants
Started: Mar 1, 2023 · Completed: Jun 30, 2026
NCT06132503Lead Sponsor
Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
PHASE1Recruiting
110 participants
Started: Jan 3, 2023 · Completed: Nov 30, 2028
NCT03643107Collaborator
Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)
PHASE2Completed
15 participants
Started: Oct 17, 2018 · Completed: Aug 1, 2022
Locations (1)
Headquarters
Dallas, TX, United States
Map
Loading map...